# Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

> **NCT02130323** · PHASE2,PHASE3 · COMPLETED · sponsor: **United States Naval Medical Center, San Diego** · enrollment: 22 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DRUG:** Imiquimod
- **PROCEDURE:** Loop Electrosurgical Excision Procedure

## Key facts

- **NCT ID:** NCT02130323
- **Lead sponsor:** United States Naval Medical Center, San Diego
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-12-21
- **Final completion:** 2017-05-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130323, "Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02130323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*